Prestige Consumer Healthcare Inc. reported total revenues of $1.138 billion for the fiscal year ending March 31, 2025, reflecting a modest increase of 1.1% compared to $1.125 billion in the previous fiscal year. The North American OTC Healthcare segment generated $960 million, accounting for 84.4% of total revenues, while the International OTC Healthcare segment contributed $178 million, representing 15.6% of total revenues. The company achieved a net income of $214.6 million, or $4.32 per share, compared to $209.3 million, or $4.21 per share, in the prior year.
The financial performance showed a slight decline in the North American segment, where revenues increased by only $1.8 million, primarily due to a rise in sales in the Gastrointestinal category, offset by a decrease in the Cough & Cold category. Conversely, the International segment saw a more significant revenue increase of $10.7 million, driven by growth in the Gastrointestinal and Dermatologicals categories. Gross profit for the year was $634.5 million, with a gross margin of 55.8%, slightly up from 55.5% in 2024, attributed to increased revenue and reduced freight costs.
Strategically, Prestige Consumer Healthcare has focused on expanding its product portfolio through acquisitions and new product launches. In 2025, the company acquired additional rights to the Hydralyte intellectual property, enhancing its international offerings. The company also launched several new products, including Summer’s Eve Whole Body Deodorant Creams and Goody’s Plus – Headache Pain + Mental Alertness. The company’s market position remains strong, with approximately 61.5% of total revenues derived from brands holding a number one market position.
Operationally, Prestige Consumer Healthcare reported a total employee headcount of approximately 600, with 82% based in the United States. The company continues to face challenges related to supply chain disruptions and inflationary pressures, which have impacted product availability and costs. The company’s reliance on a limited number of customers, including Walmart and Amazon, which accounted for 19% and 14% of gross revenues respectively, poses additional risks to its revenue stability.
Looking ahead, Prestige Consumer Healthcare anticipates continued growth in both domestic and international markets, although it acknowledges the potential for economic volatility to affect consumer spending and demand for its products. The company remains committed to enhancing its operational efficiencies and expanding its market share through strategic acquisitions and product innovation.
About Prestige Consumer Healthcare Inc.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.